Tus kws kho mob
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2451 - 2460 ntawm 3289
Tus kws kho mob
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP83-20 Preventive Care Outreach Campaign for ACA Individual and Small Group (with Carenet Health)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
2020 September Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 19, 2020
Tus kws kho mob
QP76-20 Outlier Outpatient Therapy Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020